EPY0001083 Post author:adminlaboratory Post published:2022.05.27. Post category: Post comments:0 Comments Methyldopa for system suitability Continue ReadingEPY0001083
EPY0001082 Post author:adminlaboratory Post published:2022.05.27. Post category: Post comments:0 Comments Fluvastatin for system suitability Continue ReadingEPY0001082
EPY0001081 Post author:adminlaboratory Post published:2022.05.27. Post category: Post comments:0 Comments Mefenamic acid impurity A - 2,3-dimethylaniline Continue ReadingEPY0001081
EPY0001080 Post author:adminlaboratory Post published:2022.05.27. Post category: Post comments:0 Comments Meloxicam Continue ReadingEPY0001080
EPY0001079 Post author:adminlaboratory Post published:2022.05.27. Post category: Post comments:0 Comments Benserazide for peak identification Continue ReadingEPY0001079
EPY0001078 Post author:adminlaboratory Post published:2022.05.27. Post category: Post comments:0 Comments Bicisate labelling kit Continue ReadingEPY0001078
EPY0001077 Post author:adminlaboratory Post published:2022.05.27. Post category: Post comments:0 Comments Iopromide impurity A - 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methylbenzene-1,3- dicarboxamide Continue ReadingEPY0001077
EPY0001076 Post author:adminlaboratory Post published:2022.05.27. Post category: Post comments:0 Comments Losartan for system suitability Continue ReadingEPY0001076
EPY0001075 Post author:adminlaboratory Post published:2022.05.27. Post category: Post comments:0 Comments Rifaximin for system suitability Continue ReadingEPY0001075
EPY0001074 Post author:adminlaboratory Post published:2022.05.27. Post category: Post comments:0 Comments Rifaximin Continue ReadingEPY0001074